Bladder cancer

P. Jiang; J. Dunst

doi:10.1007/978-3-662-45934-8_16

Bladder cancer

P. Jiang^*, J. Dunst

^*Corresponding author for this work

Clinic of Radiotherapy

University of Kiel

Abstract

For localized muscle-invasive bladder cancer, radical cystectomy has been widely considered as the standard treatment. However, numerous phase II studies with concurrent chemoradiotherapy have demonstrated survival rates identical to surgical series with 70–80 % bladder preservation in long-term survivors. Chemoradiation is the standard of care for organ preservation, and radiotherapy alone might offer effective palliation of symptoms, such as pain and hematuria, even in patients with very advanced disease. The principles of target volume delineation and treatment planning are outlined in this chapter.

Original language	English
Title of host publication	Target Volume Definition in Radiation Oncology
Number of pages	10
Publisher	Springer Berlin Heidelberg
Publication date	01.01.2015
Pages	323-332
ISBN (Print)	9783662459331
ISBN (Electronic)	9783662459348
DOIs	https://doi.org/10.1007/978-3-662-45934-8_16
Publication status	Published - 01.01.2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-662-45934-8_16

Cite this

@inbook{63bd5a6ff6cd4ef48ba659c57e87aeb1,

title = "Bladder cancer",

abstract = "For localized muscle-invasive bladder cancer, radical cystectomy has been widely considered as the standard treatment. However, numerous phase II studies with concurrent chemoradiotherapy have demonstrated survival rates identical to surgical series with 70–80 % bladder preservation in long-term survivors. Chemoradiation is the standard of care for organ preservation, and radiotherapy alone might offer effective palliation of symptoms, such as pain and hematuria, even in patients with very advanced disease. The principles of target volume delineation and treatment planning are outlined in this chapter.",

author = "P. Jiang and J. Dunst",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-45934-8_16",

language = "English",

isbn = "9783662459331",

pages = "323--332",

booktitle = "Target Volume Definition in Radiation Oncology",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Bladder cancer

AU - Jiang, P.

AU - Dunst, J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - For localized muscle-invasive bladder cancer, radical cystectomy has been widely considered as the standard treatment. However, numerous phase II studies with concurrent chemoradiotherapy have demonstrated survival rates identical to surgical series with 70–80 % bladder preservation in long-term survivors. Chemoradiation is the standard of care for organ preservation, and radiotherapy alone might offer effective palliation of symptoms, such as pain and hematuria, even in patients with very advanced disease. The principles of target volume delineation and treatment planning are outlined in this chapter.

AB - For localized muscle-invasive bladder cancer, radical cystectomy has been widely considered as the standard treatment. However, numerous phase II studies with concurrent chemoradiotherapy have demonstrated survival rates identical to surgical series with 70–80 % bladder preservation in long-term survivors. Chemoradiation is the standard of care for organ preservation, and radiotherapy alone might offer effective palliation of symptoms, such as pain and hematuria, even in patients with very advanced disease. The principles of target volume delineation and treatment planning are outlined in this chapter.

UR - http://www.scopus.com/inward/record.url?scp=84956839209&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-45934-8_16

DO - 10.1007/978-3-662-45934-8_16

M3 - Chapter

AN - SCOPUS:84956839209

SN - 9783662459331

SP - 323

EP - 332

BT - Target Volume Definition in Radiation Oncology

PB - Springer Berlin Heidelberg

ER -

Bladder cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this